Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36 clinical trials
Outcomes of Breast Conservative Surgery for Post Chemotherapy Tumour Size After Response to Neoadjuvant Chemotherapy

tumors who are already candidates for BCS. Another surgical advantage is down staging of the axilla so that axillary lymph node dissection can be avoided (8). Complete pathological response after

Accepts healthy volunteers
  • 0 views
  • 20 Nov, 2021
  • 1 location
Targeted Biopsy of Carbon Nanoparticles Labelled Axillary Node for cN+ Breast Cancer

To explore the feasibility of target biopsy of carbon nanoparticles labelled lymph node after neoadjuvant systemic therapy for cN+ breast cancer, and evaluate whether it can accurately predict axillary lymph node status after neoadjuvant systemic therapy.

  • 1 views
  • 01 Jul, 2022
  • 1 location
Axillary Lymph Node Dissection vs Axillary Radiotherapy in Positive Sentinel Node After Neoadjuvant Therapy (ADARNAT)

In the case of primary surgery, in patients with sentinel node involvement, it has already been shown that omitting axillary lymph node dissection (ALND), often combining axillary radiotherapy

chemotherapy regimen
axillary lymph node dissection
sentinel node
  • 0 views
  • 11 May, 2022
  • 7 locations
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

This phase III trial studies how well axillary reverse mapping works in preventing lymphedema in patients with breast cancer undergoing axillary lymph node dissection. Axillary reverse mapping

invasive breast cancer
carcinoma
carcinoma in situ
breast carcinoma
mastectomy
  • 78 views
  • 11 Apr, 2022
  • 84 locations
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS) (TAXIS)

RATIONALE: The use of tailored axillary dissection as a tailored procedure will avoid surgical overtreatment by selectively removing the lymph nodes that are affected by the cancer, thereby sparing many women the unnecessary complications of a radical surgery, providing a better quality of life while keeping the same efficacy. PURPOSE: …

  • 12 views
  • 12 Feb, 2022
  • 62 locations
Nomogram to Predict Breast Cancer Related Lymphedema

It has been hypothesized that damaged arm lymphatic drainage is associated with the arm lymphedema after axillary lymph node dissection (ALND). However, the majority of breast cancer patients

  • 10 views
  • 27 Jan, 2021
  • 1 location
Identification and Preservation of Arm Lymphatics

Controversy in axillary reverse mapping in axillary lymph node dissection (ALND) possibly results from incomplete recognition of the arm lymphatic system (ALS) and its compromise to oncological

indocyanine green
mastectomy
axillary lymph node dissection
breast cancer
cancer
  • 0 views
  • 26 Jan, 2021
  • 1 location
Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence

primary breast cancer surgery performed total mastectomy or axillary lymph node dissection. This study is a multicenter prospective study designed to validate the clinical effectiveness of repeat-SLNB

metastasis
breast cancer
partial mastectomy
seroma
lymph node dissection
  • 0 views
  • 07 Aug, 2021
  • 1 location
Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Early Breast Cancer (VENUS)

The VENUS trial is a prospective, multicenter, noninferiority, randomized, controlled clinical trial that compares sentinel lymph node biopsy versus no axillary surgery in women with early breast cancer (tumor <5cm) and node-negative after clinical palpation and axillary ultrasound.

core needle biopsy
HER2
carcinoma
erbb2
breast carcinoma
  • 0 views
  • 23 Apr, 2022
  • 9 locations
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy (ATNEC)

The aim of this study is to assess whether, omitting further axillary treatment (ALND and ART) for patients with early stage breast cancer and axillary nodal metastases on needle biopsy, who after NACT have no residual cancer in the lymph nodes on sentinel node biopsy, is non-inferior to axillary treatment …

HER2
estrogen receptor
axillary lymph node dissection
sentinel lymph node biopsy
estrogen
  • 839 views
  • 14 Jun, 2022
  • 49 locations